Composition and methods for inhibiting cell survival

Details for Australian Patent Application No. 2004213029 (hide)

Owner The Cleveland Clinic Foundation

Inventors Bauer, Joseph A.

Agent Davies Collison Cave

Pub. Number AU-A-2004213029

PCT Pub. Number WO2004/073648

Priority 60/448,501 20.02.03 US

Filing date 19 February 2004

Wipo publication date 2 September 2004

International Classifications

A61K 031/00

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2004/073648 Priority application(s): WO2004/073648

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213030-Apparatus for evaluating a patient's laryngeal cough reflex and associated methods

2004213021-Occlusion resistant hydrocephalic shunt